Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

shutterstock_512649

Merck KGaA to flog Allergopharma business to Dermapharm

February 21, 2020 Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma

German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
News
merckincweb

New Keytruda dosing schedule rejected in six cancers by the FDA

February 20, 2020 Sales and Marketing Cancer, FDA, MSD, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …
News
shutterstock_57369385

FDA approved over 1,000 generic drugs in 2019

February 20, 2020 Research and Development, Sales and Marketing FDA, generic drugs, pharma

The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
News
pfizer-building-logo1web

Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel

February 19, 2020 Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis

The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …
News
army_breast_cancer_awareness

Women who take statins could be less likely to develop ovarian cancer, study finds

February 19, 2020 Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins

A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
News

Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration

February 18, 2020 Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma

The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
News

Patient Experience: Living with multiple rare diseases

February 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …
Feature
19199400883_6db786ce0d_b

Lawsuit against FDA claims Bernie Sanders played role in approval of rival drug

February 17, 2020 Research and Development, Sales and Marketing Bernie, Bernie Sanders, Catalyst Pharmaceuticals, FDA, TRUMP FDA, US FDA

Catalyst Pharmaceutical is attempting to show in court that pressure from US Senator Bernie Sanders led to the approval of …
News
eisa0008_web

Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer

February 17, 2020 Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma

New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …
News
entrance_takeda_i020_v1

Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease

February 17, 2020 Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …
News
4829288798_876971e5d4_b

Experts call on NICE to recommended a ban on OTC codeine sales

February 17, 2020 Research and Development, Sales and Marketing Codein, NICE, opioid crisis, opioids, prescription drugs

Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish …
News
money-1811937_960_720

India considering export restrictions on antibiotics due to coronavirus

February 17, 2020 Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs

The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …
News
top_10_image_2_1_0

Top Ten most popular articles on Pharmafile.com this week

February 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Chinese Coronavirus, Wuhan, Wuhan Coronavirus, china coronavirus, coronavirus

The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …
News
eisa0008_web

Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk

February 14, 2020 Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma

The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025